nivolumab,ipilimumab,sunitinib,pazopanib
novartis,bms,pfizer
['rcc,(-irccs),(-srcc),(-urcc)', ' ipi ', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'biomarker', 'nivo', 'bionikk', 'marker ']
#gu23 kidney and biomarker analysis opening up strong w/ analysis of bionikk (mrcc w nivo vs nivo ipi or vegf tki in first line) based on ccrcc subtype, vegfr tki highest orr in ccrcc2. time to get back to subtype classification ? 
@UroOnc fellow @FCUroOnc @caseurology @JohnsHopkinsSPH grad/👦👦👦🐶mom/Health outcomes/translational 🔬 bladder@AbboshLab 🧪 Immunology @DrexelUniv